Evidence map›Paper›PMID 34201577›Full record

ArticlePathogens (Basel, Switzerland)2021

Modern Development and Production of a New Live Attenuated Bacterial Vaccine, SCHU S4

J Wayne Conlan, Anders Sjöstedt, H Carl Gelhaus, Perry Fleming, Kevan McRae, Ronald R Cobb, Roberto De Pascalis, Karen L Elkins

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

J Wayne ConlanDepartment of Human Health and Therapeutics, National Research Council-Canada, Ottawa, ON K1A 0R6, Canada.ORCID 0000-0002-3730-4935
Anders SjöstedtLaboratory for Molecular Infection Medicine Sweden (MIMS), Department of Clinical Microbiology, Umeå University, SE-901 85 Umeå, Sweden.
H Carl GelhausMRIGlobal, Kansas City, MO 64110, USA.
Perry FlemingDepartment of Human Health and Therapeutics, National Research Council-Canada, Ottawa, ON K1A 0R6, Canada.
Kevan McRaeDepartment of Human Health and Therapeutics, National Research Council-Canada, Ottawa, ON K1A 0R6, Canada.
Ronald R CobbOlogy Bioservices Inc., Alachua, FL 32615, USA.
Roberto De PascalisUS Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD 20993, USA.
Karen L ElkinsUS Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD 20993, USA.
National Research Council Canada · CACenter for Biologics Evaluation and Research · USMRIGlobal · USUmeå University · SE

Funding

Defense Threat Reduction Agency HDTRA114-AMD2-CBM-01-2-0042Defense Threat Reduction Agency HDTRA1-16-C-0028
6 · The paper itself

Abstract

Inhalation of small numbers of

Indexed as

Francisella tularensislive attenuated vaccineproduct developmenttularemia

Identifiers

PMID34201577
PMCPMC8308573
OpenAlexW3175697174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.